Context Therapeutics

CNTX NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $18 $0 $0
Gross Profit -2 16 -3 -3
EBITDA -3,820 -6,930 -6,177 -5,289
EBIT -3,823 -6,933 -6,180 -5,292
Net Income -3,667 -6,769 -5,874 -5,011
Net Change In Cash 0 18 0 0
Free Cash Flow -4,360 -7,227 -3,460 -4,631
Cash 10,089 14,449 21,676 25,137
Basic Shares 15,966 15,966 15,966 15,966

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $0 $0
Gross Profit -12 -9
EBITDA -25,060 -14,371 -7,314 -2,572
EBIT -25,072 -15,381 -10,525 -2,572
Net Income -23,964 -14,290 -7,433 6,644
Net Change In Cash 0 0 0 0
Free Cash Flow -21,047 -14,086 -9,049 -1,034
Cash 14,449 35,497 49,635 341
Basic Shares 15,966 15,966 15,966 10,959

Earnings Calls

Quarter EPS
2024-03-31 -$0.23
2023-12-31 -$0.42
2023-09-30 -$0.37
2023-06-30 -$0.31